Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates.

Zoghbi SS, Tamagnan G, Baldwin MF, Al-Tikriti MS, Amici L, Seibyl JP, Innis RB.

Nucl Med Biol. 2001 Jan;28(1):91-6.

PMID:
11182569
2.

Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.

Sorger D, Becker GA, Patt M, Schildan A, Grossmann U, Schliebs R, Seese A, Kendziorra K, Kluge M, Brust P, Mukhin AG, Sabri O.

Nucl Med Biol. 2007 Apr;34(3):331-42. Epub 2007 Feb 22.

PMID:
17383583
3.

Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.

Doll F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C.

J Med Chem. 1999 Jun 17;42(12):2251-9.

PMID:
10377231
4.

Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors.

Horti AG, Koren AO, Lee KS, Mukhin AG, Vaupel DB, Kimes AS, Stratton M, London ED.

Nucl Med Biol. 1999 Feb;26(2):175-82.

PMID:
10100216
5.

2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors.

Chefer SI, Horti AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, Mukhin AG, London ED.

Neuroreport. 1999 Sep 9;10(13):2715-21.

PMID:
10511429
6.

Synthesis and evaluation of 6-[(18)F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors.

Ding Y, Liu N, Wang T, Marecek J, Garza V, Ojima I, Fowler JS.

Nucl Med Biol. 2000 May;27(4):381-9.

PMID:
10938474
7.

Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma.

Baldwin RM, Zoghbi SS, Staley JK, Brenner E, Al-Tikriti MS, Amici L, Fujita M, Innis RB, Tamagnan G.

Nucl Med Biol. 2006 May;33(4):549-54. Epub 2006 May 2.

PMID:
16720248
8.

In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand.

Vaupel DB, Mukhin AG, Kimes AS, Horti AG, Koren AO, London ED.

Neuroreport. 1998 Jul 13;9(10):2311-7.

PMID:
9694220
9.

Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.

Saji H, Ogawa M, Ueda M, Iida Y, Magata Y, Tominaga A, Kawashima H, Kitamura Y, Nakagawa M, Kiyono Y, Mukai T.

Ann Nucl Med. 2002 May;16(3):189-200.

PMID:
12126044
10.

Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.

Mamede M, Ishizu K, Ueda M, Mukai T, Iida Y, Fukuyama H, Saga T, Saji H.

J Nucl Med. 2004 Sep;45(9):1458-70.

12.

Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.

Sihver W, Fasth KJ, Horti AG, Koren AO, Bergström M, Lu L, Hagberg G, Lundqvist H, Dannals RF, London ED, Nordberg A, Långström B.

J Neurochem. 1999 Sep;73(3):1264-72.

13.

123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.

Staley JK, van Dyck CH, Weinzimmer D, Brenner E, Baldwin RM, Tamagnan GD, Riccardi P, Mitsis E, Seibyl JP.

J Nucl Med. 2005 Sep;46(9):1466-72.

14.

Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates.

Baldwin RM, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Seibyl JP, Sybirska EH, Malison RT, Laruelle M, Charney DS, Hoffer PB, et al.

Nucl Med Biol. 1994 Oct;21(7):969-76.

PMID:
9234352
16.

Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon.

Musachio JL, Villemagne VL, Scheffel UA, Dannals RF, Dogan AS, Yokoi F, Wong DF.

Nucl Med Biol. 1999 Feb;26(2):201-7.

PMID:
10100220
17.

Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.

Fujita M, Tamagnan G, Zoghbi SS, Al-Tikriti MS, Baldwin RM, Seibyl JP, Innis RB.

J Nucl Med. 2000 Sep;41(9):1552-60.

18.

[125/123I] 5-Iodo-3-pyridyl ethers. syntheses and binding to neuronal nicotinic acetylcholine receptors.

Fan H, Scheffel UA, Rauseo P, Xiao Y, Dogan AS, Yokoi F, Hilton J, Kellar KJ, Wong DF, Musachio JL.

Nucl Med Biol. 2001 Nov;28(8):911-21.

PMID:
11711310
19.

In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography.

Chefer SI, Horti AG, Lee KS, Koren AO, Jones DW, Gorey JG, Links JM, Mukhin AG, Weinberger DR, London ED.

Life Sci. 1998;63(25):PL355-60.

PMID:
9870715
20.

Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380).

Schildan A, Patt M, Sabri O.

Appl Radiat Isot. 2007 Nov;65(11):1244-8. Epub 2007 Mar 12.

PMID:
17448665

Supplemental Content

Support Center